Yumei Zhu
4PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 11, 2026
A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China.Jie Zhao, Youhong Hu, Yumei Zhu
|Oct 13, 2021
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis.Xuan Chen, Zhiguang Yang, Guiyuan Xiang
|Mar 08, 2021
First-line atezolizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: a cost-effectiveness analysis from China.Zhiguang Yang, Yumei Zhu, Guiyuan Xiang
|Aug 07, 2019
China's policy experimentation on long-term care insurance: Implications for access.Yumei Zhu, August Österle
Pageof 1
